carmellrx.com (CTCX) - Bozor qiymatining balans qiymatiga nisbati

Carmell Corp. (CTCX) - korporativ logo

Carmell Corporation (CTCX) regenerativ biomateriallarni kengaytirish orqali o'sish strategiyasini amalga oshirmoqda. Ushbu GURU.Markets grafigida aks etgan kitob qiymatiga nisbatan narxlar tarixida -2.81 qiymati joriy ko'rsatkichni ifodalaydi. Jarrohlik uchun mo'ljallangan noyob plazma mahsulotlari barqarorlikni ta'minlaydi, biroq biznes muvaffaqiyati samarali tijoratlashtirishga va yetarli rezervlar bilan qo'llab-quvvatlanadigan operatsion xarajatlarning qat'iy nazoratiga bog'liq.

Carmell Therapeutics (CTCX) - Balans qiymatiga nisbatan bozor qiymati 21.02.2024dan 10.03.2025gacha
Carmell Corp ishlab chiqargan mahsulot

Carmell Corporation (CTCX) uzoq muddatli biomeditsina ishlanmalarini estetik kosmetika bilan olinadigan operatsion daromadlar bilan samarali birlashtiradi. Bozor qiymatining buxgalteriya qiymatiga nisbati investorlarning emitentning sof aktivlaridan yuqori bo'lgan premiumini o'lchaydi. Ushbu koeffitsient biznesning xarajatlar inflyatsiyasini qoplash qobiliyatiga bo'lgan bozor ishonchini aks ettiradi. Aktivlarning yuqori baholanishi tartibga soluvchi o'zgarishlar xavflariga qaramay, kapitalga kirishni osonlashtiradi. Narxning buxgalteriya qiymatiga nisbatining tarixi ushbu muvozanat dinamikasini aniq namoyish etadi.

Raqobatchilar tahlili

ASND (Ascendis Pharma A/S) - Kapitallashuvning sof aktivlarga nisbati|Kapitallashuvning balans qiymatiga nisbati MDGL|Bozor qiymatining balans qiymatiga nisbati Corcept Therapeutics Incorporated|Rhythm Pharma - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati AKRO|MTSR (Metsera Therapeutics) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati MLTX (MoonLake Immunotherapeutics)|Bozor kapitallashuvining balans qiymatiga nisbati crinetics.com CRNX|NAMS - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati SLNO (Soleno Therapeutics Inc)|Amicus Pharma (FOLD) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati 89bio Pharma|AGIO (Agios Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati structuretx.com|Kapitallashuvning sof aktivlarga nisbati MDXG (MiMedx)|RZLT (Rezolute Inc) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Lexicon Pharma LXRX|MBX - Kapitallashuvning sof aktivlarga nisbati|Altimmune, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti aardvarktherapeutics.com|SGMT (Sagimet Biosciences Inc.) - Kapitallashuvning sof aktivlarga nisbati|BIOA: Bozor kapitallashuvining balans qiymatiga multiplikatori|BMEA (Biomea) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Quince|Bozor kapitallashuvining balans qiymatiga nisbati GUTS|Bozor qiymatining balans qiymatiga nisbati VTVT (vtvtherapeutics.com)|Bozor qiymatining balans qiymatiga nisbati Agape ATP ATPC|Pluristem Therapeutics (PLUR) - Bozor qiymatining balans qiymatiga koeffitsiyenti|SYBX - Bozor qiymatining balans qiymatiga nisbati|LPCN: Bozor qiymatining balans qiymatiga nisbati|MTNB: Bozor kapitallashuvining balans qiymatiga nisbati|SPRB - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Galecto|Lumos Pharma Inc (LUMO) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Organovo Holdings Inc (ONVO)|Kapitallashuvning sof aktivlarga nisbati Radius Pharmaceuticals RDUS